Literature DB >> 30897376

SWI/SNF: Complex complexes in genome stability and cancer.

Cristina Ribeiro-Silva1, Wim Vermeulen2, Hannes Lans3.   

Abstract

SWI/SNF complexes are among the most studied ATP-dependent chromatin remodeling complexes, mostly due to their critical role in coordinating chromatin architecture and gene expression. Mutations in genes encoding SWI/SNF subunits are frequently observed in a large variety of human cancers, suggesting that one or more of the multiple SWI/SNF functions protect against tumorigenesis. Chromatin remodeling is an integral component of the DNA damage response (DDR), which safeguards against DNA damage-induced genome instability and tumorigenesis by removing DNA damage through interconnected DNA repair and signaling pathways. SWI/SNF has been implicated in facilitating repair of double-strand breaks, by non-homologous end-joining as well as homologous recombination, and repair of helix-distorting DNA damage by nucleotide excision repair. Here, we review current knowledge on SWI/SNF activity in the DDR and discuss the potential of exploiting DDR-related vulnerabilities due to SWI/SNF dysfunction for precision cancer therapy.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer therapy; DNA damage response; Homologous recombination; Non-homologous end-joining; Nucleotide excision repair; SWI/SNF

Mesh:

Substances:

Year:  2019        PMID: 30897376     DOI: 10.1016/j.dnarep.2019.03.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  23 in total

Review 1.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

2.  TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.

Authors:  Qiao Liu; Lei Xie
Journal:  PLoS Comput Biol       Date:  2021-02-12       Impact factor: 4.475

3.  Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways.

Authors:  Jean-Michel Lavoie; Veronika Csizmok; Laura M Williamson; Luka Culibrk; Gang Wang; Marco A Marra; Janessa Laskin; Steven J M Jones; Daniel J Renouf; Christian K Kollmannsberger
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-04-28

4.  ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.

Authors:  Yang Xiao; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

5.  Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.

Authors:  Shasha Gong; Zhijian Song; David Spezia-Lindner; Feilong Meng; Tingting Ruan; Guangzhi Ying; Changhong Lai; Qianqian Wu; Yong Liang
Journal:  Front Genet       Date:  2020-06-11       Impact factor: 4.599

6.  Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.

Authors:  Kung-Chen Ho; Jie-Jen Lee; Chi-Hsin Lin; Ching-Hsiang Leung; Shih-Ping Cheng
Journal:  Diagnostics (Basel)       Date:  2020-05-05

Review 7.  Mutations and Copy Number Abnormalities of Hippo Pathway Components in Human Cancers.

Authors:  Zhengjin He; Ruihan Li; Hai Jiang
Journal:  Front Cell Dev Biol       Date:  2021-06-03

Review 8.  Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma.

Authors:  Younglan Lim; Nam-On Ku
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

9.  Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.

Authors:  Gerhard Jungwirth; Rolf Warta; Christopher Beynon; Felix Sahm; Andreas von Deimling; Andreas Unterberg; Christel Herold-Mende; Christine Jungk
Journal:  Acta Neuropathol Commun       Date:  2019-08-30       Impact factor: 7.801

10.  SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.

Authors:  Zhao-Ming Xiao; Dao-Jun Lv; Yu-Zhong Yu; Chong Wang; Tao Xie; Tao Wang; Xian-Lu Song; Shan-Chao Zhao
Journal:  Front Cell Dev Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.